Elly Gerald Stoica

Array ( [id] => 10405309 [patent_doc_number] => 20150290318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/748634 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405309 [patent_doc_number] => 20150290318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/748634 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405309 [patent_doc_number] => 20150290318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/748634 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405300 [patent_doc_number] => 20150290309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/748579 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8256 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405309 [patent_doc_number] => 20150290318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/748634 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11481582 [patent_doc_number] => 09588119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells' [patent_app_type] => utility [patent_app_number] => 14/746859 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4481 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14746859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119801 [patent_doc_number] => 10246750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion [patent_app_type] => utility [patent_app_number] => 15/317679 [patent_app_country] => US [patent_app_date] => 2015-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11921 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13207093 [patent_doc_number] => 10117897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes [patent_app_type] => utility [patent_app_number] => 14/734969 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 28 [patent_no_of_words] => 16406 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15481367 [patent_doc_number] => 10556009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Anti-Blys antibody formulations and methods of treatment using them [patent_app_type] => utility [patent_app_number] => 15/311223 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16975 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12999983 [patent_doc_number] => 10023649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist [patent_app_type] => utility [patent_app_number] => 15/312515 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17629 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11497834 [patent_doc_number] => 20170072019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'COMPOSITIONS COMPRISING IL-31 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/310514 [patent_app_country] => US [patent_app_date] => 2015-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14650 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11541699 [patent_doc_number] => 20170095524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'METHODS FOR MODULATING CANCER CELLS AND STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/310560 [patent_app_country] => US [patent_app_date] => 2015-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10760 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11706244 [patent_doc_number] => 20170174744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'NEW METHOD FOR TREATING MELANOMA' [patent_app_type] => utility [patent_app_number] => 15/310158 [patent_app_country] => US [patent_app_date] => 2015-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11195 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14324101 [patent_doc_number] => 10293043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Methods of lowering serum cholesterol [patent_app_type] => utility [patent_app_number] => 15/313465 [patent_app_country] => US [patent_app_date] => 2015-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33212 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13129167 [patent_doc_number] => 10082510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancer [patent_app_type] => utility [patent_app_number] => 15/309143 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 19 [patent_no_of_words] => 23592 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491509 [patent_doc_number] => 20170065694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'PEPTIDE VACCINE COMPRISING MUTANT RAS PEPTIDE AND CHEMOTHERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 15/308917 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12010 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10408090 [patent_doc_number] => 20150293099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/701810 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17329227 [patent_doc_number] => 11219668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-11 [patent_title] => Method of treating a vasculopathy in a human subject [patent_app_type] => utility [patent_app_number] => 15/530196 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5022 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15530196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12750541 [patent_doc_number] => 20180142014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => ULTRA-POTENT NEUTRALIZATION OF CYTOKINES BY MULTISPECIFIC ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/568325 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11357402 [patent_doc_number] => 09534046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Antibodies to TNFα' [patent_app_type] => utility [patent_app_number] => 14/695949 [patent_app_country] => US [patent_app_date] => 2015-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 88 [patent_no_of_words] => 27933 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14695949 [rel_patent_id] =>[rel_patent_doc_number] =>)